Avanos Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	715.9	701.2	687.8	673.3	684.1	587
Revenue Growth (YoY)	3.87%	1.95%	2.15%	-1.58%	16.54%	-17.88%
Cost of Revenue	357.6	347.3	306.5	293.6	289.9	287.8
Gross Profit	358.3	353.9	381.3	379.7	394.2	299.2
Selling, General & Admin	317.6	315.6	318.5	335	326.5	285.3
Research & Development	23.1	23.3	26.2	27.2	29.2	30.6
Other Operating Expenses	77	77.4	440.6	-13.3	-3	-
Total Operating Expenses	417.7	416.3	785.3	348.9	352.7	315.9
Operating Income	-74.5	-61.6	-396.2	4.2	35.5	-39
Interest Income	1.9	3.2	5.1	2.9	1.2	0.2
Interest Expense	-7.2	-7.8	-12.2	-15	-10	-3.3
Other Non-Operating Income (Expense)	-4.7	-	-	-	-	-22.3
Total Non-Operating Income (Expense)	-10	-4.6	-7.1	-12.1	-8.8	-25.4
Pretax Income	-77.1	-66.2	-403.3	-7.9	26.7	-42.1
Provision for Income Taxes	1.1	6.7	-17	2	5.2	-11.2
Net Income	-79.5	-72.9	-386.3	-9.9	21.5	-30.9
Earnings From Discontinued Operations	-	-	-5.8	-51.9	29	37.2
Net Income to Common	84.6	72.9	392.1	61.8	-50.5	-6.3
Net Income Growth	1181.82%	-81.41%	534.47%	-	-	-
Shares Outstanding (Basic)	46	46	46	47	47	48
Shares Outstanding (Diluted)	47	46	46	47	47	49
Shares Change (YoY)	0.48%	0.65%	-1.29%	-1.48%	-2.67%	1.67%
EPS (Basic)	-1.61	-1.57	-8.53	-1.32	1.08	-0.64
EPS (Diluted)	-1.61	-1.57	-8.53	-1.32	1.07	-0.64
Free Cash Flow	7.5	43.1	82.9	14.6	71.6	66.3
Free Cash Flow Growth	-82.60%	-48.01%	467.81%	-79.61%	7.99%	-
Free Cash Flow Per Share	0.16	0.93	1.80	0.31	1.51	1.36
Gross Margin	50.05%	50.47%	55.44%	56.39%	57.62%	50.97%
Operating Margin	-10.41%	-8.78%	-57.60%	0.62%	5.19%	-6.64%
Profit Margin	-11.10%	-10.40%	-56.16%	-1.47%	3.14%	-5.26%
FCF Margin	1.05%	6.15%	12.05%	2.17%	10.47%	11.29%
EBITDA	-35	-22.7	-350.7	50.3	83.2	-0.7
EBITDA Margin	-4.89%	-3.24%	-50.99%	7.47%	12.16%	-0.12%
EBIT	-74.5	-61.6	-396.2	4.2	35.5	-39
EBIT Margin	-10.41%	-8.78%	-57.60%	0.62%	5.19%	-6.64%
Effective Tax Rate	-1.43%	-10.12%	4.22%	-25.32%	19.48%	26.60%

SEC Filings: 10-K · 10-Q